Clinical Trial Update: Evaluating the Efficacy and Safety of GB08 Injection in Pediatric Patients With Growth Hormone Deficiency [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 2/Phase 3 study of GB08 injection for pediatric growth hormone deficiency, which is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• GB08

Snippet

Sponsor: Shenzhen Kexing Pharmaceutical Co., Ltd. | Conditions: Growth Hormone Deficiency in Children, Growth Hormone Deficiency (GHD) | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING